Pacer Advisors Inc. Sells 6,492 Shares of UnitedHealth Group Incorporated $UNH

Key Points

• Pacer Advisors reduced its UnitedHealth Group stake by 6.8% in the fourth quarter, selling 6,492 shares and leaving it with 88,546 shares valued at about $29.23 million.
• UnitedHealth also saw an insider sale: CEO Patrick Hugh Conway sold 800 shares at $355 each, trimming his ownership by 4.3%.
• Analysts remain largely bullish on UNH, with several firms raising price targets and the stock carrying a consensus Moderate Buy rating; the company also raised its quarterly dividend to $2.32 per share.

Pacer Advisors Inc. trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 6.8% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,546 shares of the healthcare conglomerate's stock after selling 6,492 shares during the quarter. Pacer Advisors Inc.'s holdings in UnitedHealth Group were worth $29,230,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also made changes to their positions in the company. Brighton Jones LLC grew its stake in shares of UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after purchasing an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH purchased a new position in UnitedHealth Group in the second quarter worth about $340,000. Flow Traders U.S. LLC bought a new stake in shares of UnitedHealth Group during the second quarter valued at approximately $356,000. Finally, Jump Financial LLC purchased a new position in UnitedHealth Group in the 2nd quarter worth approximately $377,000. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 800 shares of the company's stock in a transaction that occurred on Thursday, April 23rd. The shares were sold at an average price of $355.00, for a total value of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at $6,320,775. This represents a 4.30% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 0.28% of the company's stock.

Analysts Set New Price Targets

A number of analysts have commented on UNH shares. Cantor Fitzgerald reissued an "overweight" rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Bank of America upgraded UnitedHealth Group from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $420.00 to $450.00 in a report on Thursday, June 4th. Raymond James Financial upgraded shares of UnitedHealth Group from a "market perform" rating to an "outperform" rating and set a $330.00 price target for the company in a research note on Wednesday, April 1st. Wells Fargo & Company boosted their target price on shares of UnitedHealth Group from $370.00 to $397.00 and gave the company an "overweight" rating in a research note on Wednesday, April 22nd. Finally, Morgan Stanley lifted their price objective on UnitedHealth Group from $395.00 to $453.00 and gave the stock an "overweight" rating in a report on Thursday, June 4th. One research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $409.75.

UnitedHealth Group Stock Down 0.0%

Shares of UNH stock opened at $400.86 on Friday. The company has a 50 day simple moving average of $373.69 and a two-hundred day simple moving average of $329.55. The stock has a market cap of $364.04 billion, a P/E ratio of 30.28, a P/E/G ratio of 1.61 and a beta of 0.64. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $415.98. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Tuesday, April 21st. The healthcare conglomerate reported $7.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $6.76 by $0.47. The firm had revenue of $111.65 billion during the quarter, compared to the consensus estimate of $109.84 billion. UnitedHealth Group had a net margin of 2.68% and a return on equity of 14.65%. The company's revenue for the quarter was up 2.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 18.32 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 23rd. Investors of record on Monday, June 15th will be issued a $2.32 dividend. The ex-dividend date of this dividend is Monday, June 15th. This represents a $9.28 annualized dividend and a yield of 2.3%. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.21. UnitedHealth Group's payout ratio is currently 70.09%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.